Carvedilol Tablet, Film Coated
Product Images NDC 50090-4898

6 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 50090-4898). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A line graph depicting percent mortality over 21 months comparing two groups: Placebo and Carvedilol. The y-axis shows percent mortality, and the x-axis shows months from 0 to 21. The Carvedilol group has consistently lower mortality than the Placebo group. A p-value of 0.0014 is noted on the graph.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A forest plot displaying hazard ratios for different patient subgroups including gender, age, race, diabetic status, ischemic status, heart rate categories, systolic blood pressure, spironolactone use, and all patients combined. Each subgroup is represented by a point and confidence interval on a horizontal axis labeled 'Hazard ratio' ranging from 0.0 to 2.0, with a reference line at 1.0.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A survival analysis line graph titled 'Survival Analysis for CAPRICORN (intent-to-treat)' showing % Mortality on the y-axis versus Months on the x-axis. Two curves are displayed, one labeled Placebo and the other Carvedilol, tracking mortality rates over 24 months, with a P value of 0.03 indicated on the left side of the graph.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A forest plot titled 'Effects on Mortality for Subgroups in CAPRICORN' showing hazard ratios for various patient subgroups, including age, sex, timing of randomization post-myocardial infarction, prior treatments, clinical conditions, and heart rate. The plot displays hazard ratios on the x-axis ranging approximately from 0.4 to 1.3, with confidence intervals shown as horizontal lines extending from each subgroup marker.*
FDA Label Image

Label Image (Lbl500904898)

Label Image (Lbl500904898)
Carvedilol 25 mg film-coated tablets label from A-S Medication Solutions, NDC 50090-4898. The label indicates each tablet contains 25 mg carvedilol, with storage instructions to keep at 68 to 77 degrees Fahrenheit and protect from moisture. The package contains 90 tablets. The label also includes a QR code and batch information.*
FDA Label Image

Carvedilol-chemical-structure (Structure)

Carvedilol-chemical-structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.